Diabetic patients taking GLP-1 instead of insulin have a lower risk of cancer
Type 2 diabetes patients taking GTP-1 drugs, including Ozempic, have a lower risk of developing 10 obesity-related cancers than those taking insulin and other diabetes medications, according to a study published Friday.
POPULAR POSTS
Portugal declares risk as wildfires hit the north of the country
September 17, 2024
UK to appoint nature envoy
September 17, 2024
Death tolls rises as Central Europe floods
September 17, 2024
LIVE STREAM